Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001018534-04-000001
Filing Date
2004-02-23
Accepted
2004-02-23 20:27:18
Documents
1
Period of Report
2004-02-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4926
  Complete submission text file 0001018534-04-000001.txt   6605
Mailing Address
Business Address 8271 154TH AVENUE NE REDMOND WA 98052
FRAZIER ALAN D (Reporting) CIK: 0001018534 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 04623313

Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations